Grifols (GRFS) issued a statement to address certain information published in a media outlet on March 8, specifically a front-page article ...

Grifols revenue and EBITDA growth, improved leverage ratio, and significant liquidity highlight its resilience and potential ...

Grifols shares lost more than 5% on the stock market on Monday. Last Friday, after the market had closed, a report was ...

Spanish drugmaker Grifols said on Thursday it expects its revenue, core earnings and free cash flow to grow significantly in ...

Spanish drugmaker Grifols reported on Wednesday a net profit of 157 million euros ($165.02 million) for 2024 on revenues of 7 ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

Deutsche Bank raised the firm’s price target on Grifols (GRFS) to EUR 11 from EUR 10 and keeps a Hold rating on the shares.Optimize Your ...

More than two dozen people rallied on Monday against a new for-profit clinic in Whitby that pays people for plasma donations.

Activist hedge fund Gotham lambasted healthcare firm Grifols last year. Some of its key criticisms were vindicated. And its ...

As European markets face uncertainty due to U.S. trade policy and recent ECB rate cuts, the pan-European STOXX Europe 600 Index has snapped a 10-week streak of gains, although increased defense and ...

Grifols said it expects positive free cash flow to rise to €1.2-billion in 2029 and to €350 million-€400-million in 2025 ...

BARCELONA, Feb 26 (Reuters) - Spanish drugmaker Grifols (GRLS.MC), opens new tab reported on Wednesday a net profit of 157 million euros ($165.02 million) for 2024 on revenues of 7.21 billion ...